Gobi Partners Fuels Biological Computing Boom with Strategic Investment in Cortical Labs Malaysia Hub

Gobi Partners, a leading Asia-focused venture capital firm, has announced a significant investment in Cortical Labs, advancing biological computing technologies.

The investment comes through Gobi Partners' Dana Impak Ventures fund, supported by Malaysia's sovereign wealth fund Khazanah Nasional.

Biological Computing Revolution

Cortical Labs specializes in innovative systems that integrate laboratory-grown human neurons with silicon hardware, creating hybrid biological computers.

The company's flagship CL1 platform marks the world's first commercially available biological computer, allowing real-time experiments on living neural networks.

This technology is revolutionizing central nervous system drug discovery by enabling scientists to observe neural responses to pharmaceuticals directly.

Strategic Expansion in Malaysia

Cortical Labs has established its engineering and manufacturing operations in Malaysia at SIDEC’s IC Design Park in Puchong.

The company plans to venture into chip design, seamlessly integrating biological systems with custom semiconductors.

This expansion is poised to generate jobs in neuroscience, chip design, and computational biology, bolstering Malaysia's deep-tech ecosystem.

Global Backing and Future Impact

The funding round was led by Horizon Ventures and 3C, with participation from Tom Oxley, founder of brain-computer interface pioneer Synchron.

As AI demands escalate computing power and energy, biological neural networks offer a promising, efficient alternative.

This investment underscores Malaysia's rising prominence in semiconductor engineering and advanced manufacturing.

Looking ahead, Gobi Partners aims to deepen its commitment to transformative 'uni-tech' innovations across the region.